Nonspecific suppressor cells in patients with chronic graft-vs-host disease after marrow grafting
- PMID: 39962
Nonspecific suppressor cells in patients with chronic graft-vs-host disease after marrow grafting
Abstract
Forty-four human long-term survivors after marrow transplantation for aplastic anemia or hematologic malignancy were studied for the presence of circulating nonspecific suppressor cells. Twenty-two of the patients were healthy and 22 had mild to moderately severe chronic graft-vs-host disease (GVHD). Patient mononuclear cells (of donor origin) were tested for their ability to suppress the responses of lymphocytes obtained from the respective marrow donors to alloantigens in mixed leukocyte culture (MLC) and/or to concanavalin A (Con A). Tests were carried out between 199 and 2393 (median 376) days after transplantation. Cells from only 1 of 22 patients without chronic GVHD showed suppression of donor cell blastogeneis responses. In contrast, cells from 11 of 22 patients with chronic GVHD showed more than 30% suppression of donor cell responses in MLC and/or to Con A. The finding of suppressor cells was not related to the time of testing after grafting nor to immmunosuppressive therapy. Nonspecific suppressor activity was abrogated by irradiation with 1600 rads in vitro in five of six cases tested. Nonspecific suppressor cells may be one explanation for the severe combined immunodeficiency and the recurrent infectious complications characteristic of patients with chronic GVHD.
Similar articles
-
Spontaneous and concanavalin A induced suppressor cell activity in patients undergoing bone marrow transplantation: relationship with acute and chronic graft versus host disease.J Clin Lab Immunol. 1983 Mar;10(3):121-5. J Clin Lab Immunol. 1983. PMID: 6221107
-
Graft-versus-host disease after marrow transplantation.Prog Clin Biol Res. 1986;224:139-57. Prog Clin Biol Res. 1986. PMID: 3540990
-
CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.Biol Blood Marrow Transplant. 1997 Apr;3(1):11-7. Biol Blood Marrow Transplant. 1997. PMID: 9209736
-
Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells.Bone Marrow Transplant. 1998 Dec;22(11):1057-63. doi: 10.1038/sj.bmt.1701496. Bone Marrow Transplant. 1998. PMID: 9877267
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
Cited by
-
The pathophysiology of acute graft-versus-host disease.Int J Hematol. 2003 Oct;78(3):181-7. doi: 10.1007/BF02983793. Int J Hematol. 2003. PMID: 14604275 Review.
-
The use of concanavalin A to study the immunoregulation of human T cells.Clin Exp Immunol. 1981 Nov;46(2):237-49. Clin Exp Immunol. 1981. PMID: 6461456 Free PMC article. Review. No abstract available.
-
Analysis of different protein kinase C-dependent events in T cells from allogeneic bone marrow transplantation recipients.Clin Exp Immunol. 1992 Mar;87(3):478-84. doi: 10.1111/j.1365-2249.1992.tb03023.x. Clin Exp Immunol. 1992. PMID: 1544233 Free PMC article.
-
The transfer of antigen-specific humoral immunity from marrow donors to marrow recipients.J Clin Immunol. 1986 Sep;6(5):389-96. doi: 10.1007/BF00915378. J Clin Immunol. 1986. PMID: 2429980
-
Immune reconstitution following bone marrow transplantation.Cancer Immunol Immunother. 1993 Nov;37(6):351-60. doi: 10.1007/BF01526790. Cancer Immunol Immunother. 1993. PMID: 8242659 Free PMC article. Review. No abstract available.